Seahorse Bioscience Bags $5M

Xconomy Boston — 

Seahorse Bioscience , a biomedical instrument company based in Billerica, MA, announced today that it has closed a $5 million Series D financing round. Participants in the round include return investors Commonwealth Capital Ventures, Rock Maple Ventures,  and Life Sciences Partners, and new investors FLIR Systems, Oxford Bioscience Partners, Healthcare Ventures, New Science Ventures, and HLM Venture Partners. Seahorse will use the money to beef up international sales, marketing, and manufacturing of its XF series of instruments, which measure energy in cells are used as a tool for cancer research.